Prime Movers Lab — 2023 Investments
3 investments dated 2023 · listed companies and verified rows first · show all
San Jose, US
Ryan Sanders(Director)Robert Youngjohns(Director)
BoardZach Bratun-Glennon(Director)in
Board seatGaetano Crupi· per SEC Form D · $320M raise · filed Feb 2024
Co-investorsGradient Ventures
BiotechMedford, US
Michael R. Hufford(Director)James Jenson(Executive Officer, Director)David Gill(Executive Officer)
BoardAlexander Pickett(Director)Justin Briggs(Director)inTamim Hamad J.J Al-Thani(Director)
Board seatAmy Kruse· per SEC Form D
Paradromics develops a brain-computer interface (BCI) system, with FDA Breakthrough Device Designations for speech decoding and digital device control, and works with academic medical institutions on translational BCI research.
BiotechDeep TechHealthtechMedical DevicesAustin, US
Matt Angle(Founder and CEO)in
Board seatZia HuqueAmy Kruse· per SEC Form D
Co-investors15th RockAlpha EdisonAnthropy PartnersCapital FactoryCoastCapFrontier Path VC+14 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.